| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992859 | Journal of Thoracic Oncology | 2007 | 7 Pages |
Abstract
Detection of common EGFR mutations seems to be useful for selecting patients with NSCLC who would likely benefit from gefitinib monotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kimihide MD, PhD, Yasushi MD, PhD, Ji Young MD, Junichi MD, Yoshitsugu MD, PhD, Keitaro MD, PhD, Takayuki MD, Tetsuya MD, PhD, Toyoaki MD, PhD,